0001209191-14-021388.txt : 20140318 0001209191-14-021388.hdr.sgml : 20140318 20140318160522 ACCESSION NUMBER: 0001209191-14-021388 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140314 FILED AS OF DATE: 20140318 DATE AS OF CHANGE: 20140318 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUESTCOR PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000891288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330476164 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1300 NORTH KELLOGG DRIVE STREET 2: SUITE D CITY: ANAHEIM STATE: CA ZIP: 92807 BUSINESS PHONE: 714-786-4200 MAIL ADDRESS: STREET 1: 1300 NORTH KELLOGG DRIVE STREET 2: SUITE D CITY: ANAHEIM STATE: CA ZIP: 92807 FORMER COMPANY: FORMER CONFORMED NAME: CYPROS PHARMACEUTICAL CORP DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Young David CENTRAL INDEX KEY: 0001378166 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14758 FILM NUMBER: 14700972 MAIL ADDRESS: STREET 1: 8850 STANFORD BOULEVARD STREET 2: SUITE 2500 CITY: COLUMBIA STATE: MD ZIP: 21045 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-03-14 0 0000891288 QUESTCOR PHARMACEUTICALS INC QCOR 0001378166 Young David 1300 NORTH KELLOGG DRIVE SUITE D ANAHEIM CA 92807 0 1 0 0 Chief Scientific Officer Common Stock 2014-03-14 4 M 0 6000 4.54 A 117741 D Common Stock 2014-03-14 4 S 0 2587 61.7841 D 115154 D Common Stock 2014-03-14 4 S 0 3413 62.6526 D 111741 D Stock Option (right to buy) 4.54 2014-03-14 4 M 0 6000 0.00 D 2019-10-29 Common Stock 6000 77000 D Non-qualified stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan on 10/30/2009. The option was granted on 10/30/2009 for the right to buy 350,000 shares of common stock of the Issuer. The option provided for monthly vesting over 48 months from the date of grant with a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.47 -$62.46 and $62.50 - $62.85, respectively. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan (the "Automatic Trading Plan") adopted by the reporting person in the fourth quarter of 2013 and effective 30 days post-adoption. There have been no changes to the Automatic Trading Plan since its adoption, and there have been no sales by the Reporting Person outside of the Automatic Trading Plan since its adoption. The Automatic Trading Plan controls the exact dates and amounts of sales. /s/ David Young 2014-03-18